Solid-phase synthesis of 3-alkyl-8-arylamino-1H-imidazo[4,5-g]quinazolin-2(3H)-thiones and 3-alkyl-8-arylamino-1H-imidazo[4,5-g]quinazolin-2(3H)-ones

Tetrahedron Letters

Volumn 48, Issue 39, 2007, Pages 7042-7045

  Zhang, Yandong ^a   Zhou, Qiaosheng ^a   Houghten, Richard A ^a,b   Yu, Yongping ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

Imidazoquinazoline derivatives; Scaffold approach; Solid phase synthesis

Indexed keywords

3 ALKYL 8 ARYLAMINO 1H IMIDAZO[4,5 G]QUINAZOLIN 2(3H) ONE DERIVATIVE; 3 ALKYL 8 ARYLAMINO 1H IMIDAZO[4,5 G]QUINAZOLIN 2(3H) THIONE DERIVATIVE; 4 CHLORO 7 FLUORO 6 NITROQUINAZOLINE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG STRUCTURE; DRUG SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; SOLID PHASE SYNTHESIS;

EID: 34548254478     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.07.134     Document Type: Article

References (20)

1. Merrifield R.B. J. Am. Chem. Soc. 85 (1963) 2149
2. Dolle R.E., Le Bourdonnec B., Morales G.A., Moriarty K.J., and Salvino J.M. J. Comb. Chem. 8 (2006) 597
3. Horton D.A., Bourne G.T., and Smythe M.L. Chem. Rev. 103 (2003) 893
4. Nefzi A., Ostresh J.M., Yu Y., and Houghten R.A. J. Org. Chem. 69 (2004) 3603
5. Yu Y., Ostresh J.M., and Houghten R.A. J. Comb. Chem. 6 (2004) 83
6. Zhang Y., Xu C., Yu Y., and Houghten R.A. J. Comb. Chem. 9 (2007) 11
7. Wenzel D.G. J. Am. Pharm. Assoc. 44 (1955) 550
8. Hori M., Iemura R., Hara H., Ozaki A., Sukamoto T., and Ohtaka H. Chem. Pharm. Bull. 38 (1990) 681
9. Hayao S., Havera H.J., Stryeker H.E.W.G., Leipzig T.G., Kulp R.A., and Hartzler H.E. J. Med. Chem. 8 (1965) 807
10. Nishikawa Y., Shindo T., Ishii K., Nakamura H., Kona T., and Uno H. J. Med. Chem. 32 (1989) 583
11. Havera H.J., and Vidrio H.J. J. Med. Chem. 22 (1979) 1548
12. Chao Q., Deng L., Shih H., Leoni L.M., Genini D., Carson D.A., and Cottam H.B. J. Med. Chem. 42 (1999) 3860
13. Kung P.P., Casper M.D., Cook K.L., Wilson-Lingardo L., Risen L.M., Vickers T.A., Ranken R., Blyn L.B., Wyatt J.R., Cook P.D., and Ecker D.J. J. Med. Chem. 42 (1999) 4705
14. Glaser T., and Traber J. Agents Actions. 15 (1984) 341
15. Liverton N.J., Armstrong D.J., Claremon D.A., Remy D.C., Bardwin J.J., Lynch R.J., Zhang G., and Gould R.J. Bioorg. Med. Chem. Lett. 8 (1998) 483
16. Yasuo, O.; Yuji, N.; Tetsuji, O.; Koji, Y.; Michio, I. World Patent 9,808,848 March 5, 1998.
17. Daisuke, M.; Haruki, T.; Tetuji. O.; Ken, N.; Kenji, M.; Iwao, K.; Yuji, N.; Tomoko, I. World Patent 9,506,648 March 9, 1995.
18. Barker; Mereside, A. J.; Park, A.; Cheshire, M. European Patent 635,507 July 15, 1994.
19. Pamukeu, R.; Piazza, G. A. U.S. Patent 2002,193,389 May 30, 2002.
20. The 4-chloro-7-fluoro-6-nitroquinazoline scaffold was prepared according to the literature:. J. Med. Chem. 39 (1996) 918